BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12429820)

  • 1. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders.
    Paessler M; Kossev P; Tsai D; Raghunath P; Majewski M; Zhang Q; Ramalingam P; Schuster S; Tomaszewski J; Arber DA; Hsi E; Wasik MA
    Lab Invest; 2002 Nov; 82(11):1599-606. PubMed ID: 12429820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders.
    Abed N; Casper JT; Camitta BM; Margolis D; Trost B; Orentas R; Chang CC
    Bone Marrow Transplant; 2004 Feb; 33(3):321-7. PubMed ID: 14688820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts.
    Sugita Y; Tokunaga O; Nakashima A; Shigemori M
    Pathol Int; 2004 Sep; 54(9):659-66. PubMed ID: 15363033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas.
    King BE; Chen C; Locker J; Kant J; Okuyama K; Falini B; Swerdlow SH
    Mod Pathol; 2000 Nov; 13(11):1219-31. PubMed ID: 11106080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells.
    Carbone A; Gloghini A; Larocca LM; Antinori A; Falini B; Tirelli U; Dalla-Favera R; Gaidano G
    Blood; 1999 Apr; 93(7):2319-26. PubMed ID: 10090942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
    Carbone A; Gaidano G; Gloghini A; Larocca LM; Capello D; Canzonieri V; Antinori A; Tirelli U; Falini B; Dalla-Favera R
    Blood; 1998 Feb; 91(3):747-55. PubMed ID: 9446632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.
    Bai M; Panoulas V; Papoudou-Bai A; Horianopoulos N; Kitsoulis P; Stefanaki K; Rontogianni D; Agnantis NJ; Kanavaros P
    Leuk Lymphoma; 2006 Mar; 47(3):495-501. PubMed ID: 16396774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl.
    Bai M; Skyrlas A; Agnantis NJ; Kamina S; Tsanou E; Grepi C; Galani V; Kanavaros P
    Mod Pathol; 2004 Jul; 17(7):847-56. PubMed ID: 15073604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BCL-6 protein and CD138/syndecan-1 as B-cell markers in Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G
    Int J Biol Markers; 1999; 14(3):144-8. PubMed ID: 10569135
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin.
    Lin CH; Kuo KT; Chuang SS; Kuo SH; Chang JH; Chang KC; Hsu HC; Tien HF; Cheng AL
    Clin Cancer Res; 2006 Feb; 12(4):1152-6. PubMed ID: 16489068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated expression of SHP-1 in Burkitt lymphomas and germinal center B lymphocytes.
    Delibrias CC; Floettmann JE; Rowe M; Fearon DT
    J Exp Med; 1997 Nov; 186(9):1575-83. PubMed ID: 9348315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
    Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
    Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
    Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
    J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
    de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
    Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.
    Bodoor K; Matalka I; Hayajneh R; Haddad Y; Gharaibeh W
    Asian Pac J Cancer Prev; 2012; 13(7):3037-46. PubMed ID: 22994707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrocytoid plasma cells of the germinal center.
    Lampert IA; Van Noorden S; Wotherspoon AC
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):124-31. PubMed ID: 15894923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 20. Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation.
    Novoa-Takara L; Perkins SL; Qi D; Shidham VB; Vesole DH; Hariharan S; Luo Y; Ewton A; Chang CC
    Am J Clin Pathol; 2005 Jan; 123(1):104-12. PubMed ID: 15762285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.